CRH PLC Announces 2023 Annual Report on Form 10-K
DUBLIN, IRELAND / ACCESSWIRE / February 29, 2024 / The Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "2023 Annual Report") has been published by the Company and was filed with the U.S. Securities and Exchange Commission (the "SEC") today. This is available to view on the Company's website at: www.crh.com.
The 2023 Annual Report has also been submitted to the U.K. National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
Shareholders may request to receive a physical copy of the Company's complete audited financial statements (as included in the 2023 Annual Report and prepared in accordance with U.S. GAAP) free of charge upon request to companysecretarysoffice@crh.com or by regular mail to The Company Secretary, CRH plc, 42 Fitzwilliam Square, Dublin 2, Ireland. The 2023 Annual Report is expected to be mailed to those shareholders who have requested a physical copy on March 27, 2024.
Contact:
Neil Colgan
Company Secretary
Tel: 00 3531 6344340
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: CRH PLC
View the original press release on accesswire.com
-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting